twitter Tweet

Targeted ‘radioligand’ improves survival in advanced prostate cancer

Injected agent targets radiation to prostate cancer cells, sparing most normal tissues
Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X